Cardiac Mapping Market Projected to Reach USD 6.98 Billion by 2034, Driven by Technological Advances and Growing Cardiac Disease Prevalence
30 janv. 2024 06h05 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Cardiac Mapping Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global landscape...
Global Cardiac Ablation Device Market Set for Remarkable Growth, Fueled by Rising Demand for Minimally Invasive Procedures and Technological Advancements
30 oct. 2023 08h13 HE
|
Research and Markets
Dublin, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Cardiac Ablation Devices Market" report has been added to ResearchAndMarkets.com's offering. Rising incidents of cardiac arrhythmia and the...
The Rise of Pulsed Field Ablation: A Safer, Minimally Invasive Solution for Atrial Fibrillation and Cardiac Arrhythmias
18 oct. 2023 06h28 HE
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Areas, Source of Ablation, and Key Geographical Regions: Market Share...
Global Cardiac Ablation Strategic Business Report 2023: Innovative Technologies Assist in Enhancing AF Ablation Process
15 juin 2023 07h38 HE
|
Research and Markets
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Cardiac Ablation: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cardiac Ablation...
Worldwide Cardiac Ablation Catheters Industry to 2025 - US is Expected to Experience the Most Rapid Growth
13 juil. 2021 05h28 HE
|
Research and Markets
Dublin, July 13, 2021 (GLOBE NEWSWIRE) -- The "Cardiac Ablation Catheters Market" report has been added to ResearchAndMarkets.com's offering. In 2019, an estimated 1,115,550 cardiac catheter...
BioSig Technologies Signs Agreement to Conduct Pre Clinical Studies at UCLA
29 juil. 2015 08h00 HE
|
BioSig Technologies, Inc.
MINNEAPOLIS, July 29, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies (OTCQB:BSGM), a medical device company developing PURE EP(TM), a proprietary technology platform designed to improve the fidelity of...
BioSig Technologies, Inc. Appoints David Weild to Its Board of Directors as Audit Committee Chairman
26 mai 2015 08h00 HE
|
BioSig Technologies, Inc.
MINNEAPOLIS, May 26, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) today announced that it has appointed David Weild to the Board of Directors, effective immediately. Mr. Weild has...
BioSig Technologies to Present at the Marcum MicroCap Conference in New York on May 27
20 mai 2015 08h20 HE
|
BioSig Technologies, Inc.
MINNEAPOLIS, May 20, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies (OTCQB:BSGM), a medical device company developing PURE EP(TM) a proprietary technology platform designed to improve the clarity of...
Michele Chin-Purcell, Ph.D., to Join BioSig Technologies as Vice President, Quality and Regulatory Affairs
11 mai 2015 08h00 HE
|
BioSig Technologies, Inc.
MINNEAPOLIS, May 11, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies (OTCQB:BSGM), a medical device company developing PURE EP(TM) a proprietary technology platform designed to improve the clarity of...
BioSig Executive Leadership to Attend Heart Rhythm Society's 36th Annual Scientific Sessions, May 13 - 16, 2015 in Boston, MA
28 avr. 2015 08h00 HE
|
BioSig Technologies, Inc.
LOS ANGELES, April 28, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies (OTCQB: BSGM) executive leadership will be attending the Heart Rhythm Society's 36th Annual Scientific Sessions from May 13 –...